Skip to main content

Table 2 Clinical variables for the 38 leprosy patients broken down according to aPL antibody positivity or negativity at the sera collected in 2010/2011

From: Epidemiological, clinical and immune factors that influence the persistence of antiphospholipid antibodies in leprosy

VariablesSerum aPL (2010/2011 collected sera)p-value
NegativePositiveTotal
N%n%N%
Vascular Thrombosis1*
 No6100.0%3196.9%3797.4%
 Yes00.0%13.1%12.6%
Pregnancy Morbidity1*
 No6100.0%3196.9%3797.4%
 Yes00.0%13.1%12.6%
Diabetes1*
 No6100.0%3093.8%3694.7%
 Yes00.0%26.3%25.3%
Smoking0.670*
 No350.0%2062.5%2360.5%
 Yes350.0%1237.5%1529.5%
Alcoholism0.315*
 No583.3%3196.9%3694.7%
 Yes116.7%13.1%25.3%
  1. *Chi-square test